Merck & Co (MRK) Stock Price, Quote, News & History | Benzinga

Merck & Co Inc (MRK) Stock Price, Quote, News & History

MRKNYSE

Trade with Public

Trade with Public

$135.84

0.290.21%

At close: Aug 13, 5:00 PM EST

$135.49

-0.06-0.04%

Pre-Market: 4:23 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

-

Close

$135.84

Volume / Avg.

1.70K / 10.12M

Day Range

- - -

52 Wk Range

77.58 - 135.97

Market Cap

$334.28B

P/E Ratio

108.67

Dividend Yield

2.50%

Exchange

NYSE

RSI

67

Short Interest

1.15%

Days to Cover

3.25

Recent Merck & Co Inc News

QUICK SPARK: Dell, JPMorgan, Merck All Mark New All-Time Highs

Dell, JPMorgan and Merck hit all-time highs on Thursday. Michael Dell's wealth surged, making him the fifth richest person globally.

Erica Kollmann

Big Pharma's Future Growth Rests on Chinese Science? Expert Says: 'We Can't Ban Our Way Out of This'

China’s science surge is reshaping global drug development as Washington moves to counter Beijing’s growing influence in medicine.

Mohd Haider

Trump Cuts Core Childhood Vaccine Recommendations to 11, Bill Cassidy Says 'This Executive Order Is Wrong' (UPDATED)

President Donald Trump signed an order Monday limiting core childhood vaccine recommendations to 11 vaccines.

Radhika Anilkumar Nadig

Why Merck Just Slashed Its Profit Outlook By Nearly 50%

Merck cuts FY2026 adjusted EPS outlook nearly in half to $2.66-$2.76, citing $2.43/share in charges from its Terns acquisition.

Vandana Singh

Merck-Backed Lab Gets $8.5 Million to Fast-Track a Vaccine for a Rapidly Spreading Ebola Outbreak

Merck and Wellcome-backed Hilleman will manufacture Bundibugyo Ebola vaccine doses for clinical trials with up to $8.5M in CEPI funding.

Tanya Rawat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

19.97B

Investing Cash Flow (TTM)

-27.30B

Financing Cash Flow (TTM)

6.17B

Free Cash Flow (TTM)

16.06B

Capital Expenditure (TTM)

-3.90B

Net Change in Cash (TTM)

-1.16B

Analyst Trends and Forecast

2

Apr

1

1

May

2

Jun

6

2

Jul

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$381.91B

PE Ratio (TTM)

108.67

PE Ratio (FWD)

49.51

PEG Ratio (TTM)

13.00

PS Ratio (TTM)

5.06

PB Ratio (TTM)

7.99

Earnings Yield % (TTM)

0.92%

Earnings Yield % (FWD)

2.02%

EV / EBITDA (TTM)

26.51

Price / EBITDA (TTM)

23.40

Price / Free Cash Flow (TTM)

20.99

Book Value / Share

$17.00

Company Debt

Total Debt

$53.91B

LT Debt

$51.08B

LT Debt Issuance (TTM)

$19.84B

LT Debt Repayment (TTM)

-$1.15B

Total Cash

$6.85B

Debt to Equity

1.29

Issuance of Debt (TTM)

$18.69B

Repayment of Debt (TTM)

-$7.15B

Key Statistics

Open

-

Close

$135.84

Volume / Avg.

1.70K / 10.12M

Day Range

- - -

52 Wk Range

77.58 - 135.97

Market Cap

$334.28B

P/E Ratio

108.67

Dividend Yield

2.50%

Exchange

NYSE

RSI

67

Short Interest

1.15%

Days to Cover

3.25

About

Sector

Health Care

Industry

Pharmaceuticals

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to ov...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Merck & Co (MRK) stock?

A

You can purchase shares of Merck & Co (NYSE:MRK) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Merck & Co (MRK) competitors?

A

Other companies in Merck & Co’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Novartis AG (NYSE:NVS), AstraZeneca PLC (NYSE:AZN) and Novo Nordisk AS (NYSE:NVO).

Q

What is the forecast, or price target, for Merck & Co (MRK) stock?

A

Merck & Co has a consensus price target of $129.88.

Q

What is the current price for Merck & Co (MRK)?

A

The stock price for Merck & Co (NYSE: MRK) is $135.49 last updated August 17, 2026 at 3:28 AM EDT.

Q

Does Merck & Co (MRK) pay a dividend?

A

There are no upcoming dividends for Merck & Co.

Q

When is Merck & Co (NYSE:MRK) reporting earnings?

A

Merck & Co does not have any upcoming earnings scheduled.

Q

Is Merck & Co (MRK) going to split?

A

There is no upcoming split for Merck & Co.

Q

What sector and industry does Merck & Co (MRK) operate in?

A

Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.